Related Experiment Videos
Tricyclic use in the cognitively impaired elderly
The Journal of Clinical Psychiatry
|September 1, 1983
Summary
Tricyclic antidepressants (TCAs) may help elderly depression symptoms, with rare memory issues in those without prior organicity. Clinical improvement from TCAs can outweigh anticholinergic effects, potentially improving memory.
Area of Science:
- Geriatric Psychiatry
- Neuropharmacology
- Cognitive Neurology
Background:
- Tricyclic antidepressants (TCAs) are used for depression in the elderly.
- The relationship between TCAs, depression, and dementia in older adults is complex and not fully understood.
- Existing research presents mixed findings on TCA efficacy and cognitive side effects in this population.
Purpose of the Study:
- To review the intricate connections between tricyclic antidepressant effects, depression, and dementia in elderly individuals.
- To evaluate the efficacy and cognitive impact of TCAs in older patients, particularly those with organic disorders and depressive symptoms.
- To synthesize available data on the incidence of TCA-induced memory deficits and confusional states.
Main Methods:
- Review of existing literature and studies on tricyclic antidepressant use in elderly patients.
- Analysis of data concerning TCA efficacy in patients with organic disorders and depressive symptoms.
- Examination of studies investigating cognitive effects of TCAs in both nonelderly and elderly populations.
Main Results:
- TCAs show some efficacy in elderly patients with organic disorders and depressive symptoms like pseudobulbar affect.
- Memory deficits or confusional states from TCAs are uncommon in patients without pre-existing organicity.
- In older depressed patients, no significant link was found between TCA response and baseline or during-trial cognitive impairment.
- An ongoing study suggests clinical improvement from imipramine and trimipramine outweighs anticholinergic effects, leading to better memory.
Conclusions:
- Tricyclic antidepressants can be effective for certain depressive symptoms in the elderly, with a low risk of cognitive impairment in most.
- Cognitive improvement from depression relief may counteract potential drug-induced memory impairment at higher doses.
- Ongoing research indicates that the overall clinical benefits of TCAs in older adults, including memory enhancement, can surpass their anticholinergic side effects.